Investor's Business Daily on MSN
Eli Lilly's pill lags Novo Nordisk's in first week. Why stock rallied.
Eli Lilly's oral weight-loss drug, Foundayo, nabbed 1,390 prescriptions in its first week on the market, analysts said Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results